Related Experiment Video
Updated: Aug 25, 2026

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review
Published on: March 27, 2026
"Hamartoma" of the spleen (splenoma) in children
Carlos Abramowsky1, Carlos Alvarado, J Bradley Wyly
1Department of Pathology, Emory University School of Medicine, Egleston Children's Hospital, 1405 Clifton Road, Atlanta, GA 30322, USA. cabramo@emory.edu
Insights
Pediatric splenomas, uncommon splenic growths, are often linked to hematologic disorders. Splenectomy improved blood values in four young patients, suggesting splenomas are a fibro-inflammatory reaction, not true hamartomas.
Area of Science:
- Pediatric Pathology
- Hematology
- Surgical Oncology
Background:
- Splenic hamartomas (splenomas) are rare benign splenic tumors, poorly characterized in pediatric populations.
- These growths are often associated with various hematologic conditions, impacting spleen function and patient health.
Purpose of the Study:
- To characterize the clinicopathologic features of splenic "hamartomas" in children.
- To investigate the relationship between these splenic lesions and underlying hematologic disorders.
- To evaluate the therapeutic outcome of splenectomy in affected pediatric patients.
Main Methods:
- Retrospective analysis of four pediatric patients (ages 4-11) with splenomegaly and splenic nodules.
- Review of clinical data, imaging studies (CT, MRI, ultrasonography), and histopathologic findings.
- Histologic examination included assessment of cellular proliferation (Ki-67) and reticulin staining.
Main Results:
- Four pediatric patients presented with splenomegaly and splenic nodules associated with diverse hematologic conditions.
- Histology revealed red pulp alterations with fibro-inflammatory changes, extramedullary hematopoiesis, and siderotic deposits, lacking a capsule.
- Low Ki-67 proliferation index (<5%) was observed in both nodules and surrounding splenic tissue.
Conclusions:
- Splenic nodules in children with hematologic disorders are likely splenomas, representing a reactive fibro-inflammatory process rather than true hamartomas.
- These lesions are associated with underlying hematologic conditions and hypersplenism.
- Splenectomy is an effective therapeutic approach, leading to significant improvement in hematologic parameters post-operatively.
Abstract:
Hamartomas of the spleen or splenomas, are uncommon benign tumorous growths in this organ which have not been well characterized in children. We report four patients, 4 to 11 years old, who had splenomegaly and splenic "hamartomas" associated with different hematologic conditions (refractory microcytic anemia, sickle cell anemia, hereditary spherocytosis, and dyserythropoietic hemolytic anemia). All patients had total splenectomy as a primary therapeutic approach or to lessen their transfusion requirements. In only one patient was a focal splenic mass identified preoperatively with contrasted computed tomography (CT) scans and magnetic resonance imaging (MRI). None of the patients showed a mass by ultrasonography. Gross examination showed enlarged spleens (315-724 g) which on cut surface revealed a single nodule in one and multiple bulging nodules in three specimens. The nodules varied from 1.3 to 7 cm and were indistinct from the surrounding nonlymphoid splenic (i.e., red pulp) parenchyma. Histology of the nodules showed red splenic pulp with variable histiocytic proliferation, focal extramedullary hematopoiesis, lympho-plasmacytosis, fibrosis, and siderotic-calcific deposits. Intranodular small T- and B-cell lymphoid aggregates but no organized secondary follicles or periarteriolar sheaths were seen. Proliferation antigen Ki-67 (Mib-1) immunostains showed a low (< 5%) proliferation index in the nodules and surrounding tissue. Reticulin stains did not show a capsule or border between the normal spleen and the nodules. The critical histologic differential diagnosis for these lesions is with benign vascular tumors. These can be identified by their more disorderly pattern, by immunohistochemistry and by their higher proliferation index. It is our contention that these splenic nodules are not true hamartomas, as they seem to result from remote ischemic or infectious/inflammatory insults, leading to the fibro-inflammatory reaction and deposition of calcium and hemosiderin that is better designated with the descriptive term of splenoma. Review of the literature and our own experience indicates that most children with splenic hamartomas or splenomas as we prefer to call them, have an underlying hematologic disorder likely made worse by a state of hypersplenism that explains the consistent improvement in the blood values after splenectomy.
Related Concept Videos
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Multipotency of Hematopoietic Stem Cells